Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Clinical Significance of the CD163+ and CD68+ Macrophages in Patients with Hepatocellular Carcinoma

29 Mar 2013

Abstract excerpt

Our previous study has found that the abundance of peritumoral CD68(+) macrophages was associated with poor prognosis in hepatocellular carcinoma (HCC) after resection. However, CD68 staining could not discriminate the protumoral or tumoricidal subpopulations from pan-macrophages. CD163 is a marker of alternatively activated macrophages. In this study, the clinical significance of CD163(+) cells in tumors and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immune Cell Function and Interaction
Share to Immune cells in cancer
Share to Inflammatory Biomarkers in Disease Prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23555776
DOI: 10.1371/journal.pone.0059771

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Clinical Significance of the CD163+ and CD68+ Macrophages in Patients with Hepatocellular CarcinomaPMID 23555776Read ↗

Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinomaSemantic proximity Read ↗

Prognostic value of CD163+ macrophages in solid tumor malignancies: A scoping reviewSemantic proximity Read ↗

Prognostic value and predictive biomarkers of phenotypes of tumour-associated macrophages in colorectal cancer.Semantic proximity Read ↗

The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson's disease.Semantic proximity Read ↗

Targeting of CD163+ Macrophages in Inflammatory and Malignant DiseasesSemantic proximity Read ↗

The distribution of intratumoral macrophages correlates with molecular phenotypes and impacts prognosis in colorectal carcinoma.Semantic proximity Read ↗

Prognostic value and predictive biomarkers of tumor-associated macrophages and cancer stem cells cooperatively in colorectal cancerSemantic proximity Read ↗

Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and CSemantic proximity Read ↗

The macrophage activation marker CD163 is associated with IL28B genotype and hepatic inflammation in chronic hepatitis C virus infected patients.Semantic proximity Read ↗

Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitisSemantic proximity Read ↗

Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer.Semantic proximity Read ↗

Liver myofibroblasts up-regulate monocyte CD163 expression via PGE2 during hepatitis B induced liver failure.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.